| AMRX Stock | | | USD 9.20 0.47 5.38% |
Amneal Pharmaceuticals, financial indicator trend analysis is way more than just evaluating Amneal Pharmaceuticals, prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Amneal Pharmaceuticals, is a good investment. Please check the relationship between Amneal Pharmaceuticals, Operating Income and its Net Income accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Amneal Pharmaceuticals, Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
Operating Income vs Net Income
Operating Income vs Net Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Amneal Pharmaceuticals, Operating Income account and
Net Income. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Amneal Pharmaceuticals,'s Operating Income and Net Income is 0.83. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Net Income in the same time period over historical financial statements of Amneal Pharmaceuticals, Class, assuming nothing else is changed. The correlation between historical values of Amneal Pharmaceuticals,'s Operating Income and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Amneal Pharmaceuticals, Class are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Operating Income i.e., Amneal Pharmaceuticals,'s Operating Income and Net Income go up and down completely randomly.
Correlation Coefficient | 0.83 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Operating Income
Operating Income is the amount of profit realized from Amneal Pharmaceuticals, operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Amneal Pharmaceuticals, Class is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Amneal Pharmaceuticals, financial statement analysis. It represents the amount of money remaining after all of Amneal Pharmaceuticals, Class operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most indicators from Amneal Pharmaceuticals,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Amneal Pharmaceuticals, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Amneal Pharmaceuticals, Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
At this time, Amneal Pharmaceuticals,'s
Enterprise Value Over EBITDA is fairly stable compared to the past year.
Enterprise Value Multiple is likely to rise to 16.92 in 2024, whereas
Selling General Administrative is likely to drop slightly above 281.2
M in 2024.
Amneal Pharmaceuticals, fundamental ratios Correlations
Click cells to compare fundamentals
Amneal Pharmaceuticals, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Amneal Pharmaceuticals, fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Amneal Stock Analysis
When running Amneal Pharmaceuticals,'s price analysis, check to
measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to
predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.